Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Energy Remains in Focus During Ukraine Crisis

(File image.) The cost of living just keeps getting more expensive. This week saw headlines in the news around the rise in US inflation, up 8.5% over the year to the end of March, to hit its highest rate since 1981. The war in Ukraine drove up energy costs f...
Stockhouse Editorial | April 13, 2022 |

17 best payday loans online: Quick cash and fast approval this Christmas

If you face a financial emergency, traditional loans may not be a viable option if you have bad credit. So what can you do when you need quick cash – especially close if you need cash for Christmas gifts during the festive season? The best online payday loans are an a...
Dominic Castleberry | December 11, 2023 |

Buzz on the Bullboards: Weathering the Storm?

Sponsored by Now that we’re officially in the second half of 2022, analysts are warning that the rest of the year could prove to be challenging for the stock market. While the first half of the year a...
Jocelyn Aspa | July 7, 2022 |

Standard Lithium Arranges C$5 Million Convertible Loan Financing

The Critical Investor delves into a lithium company's financing and its implications. It seems more and more likely that Standard Lithium Ltd. (SLL:TSX.V; STLHF:OTCQX; FRA: S5L) is displaying a serious commitment of giant JV partner Lanxess these days, with constr...
Streetwise Reports | November 6, 2019 |

Syndax Pharma Shares Rise on $35M Capital Raise, Credit Line and Positive Phase 1/2 Leukemia ...

Syndax Pharma Shares Rise on $35M Capital Raise, Credit Line and Positive Phase 1/2 Leukemia Trial Results Syndax Pharmaceuticals' shares traded 30% higher after the company reported it expects to raise $35 million from a common stock offering from five instituti...
Streetwise Reports | February 3, 2020 |

Daily Gold News: Tuesday, May 19 – Gold Backs From April’s High

The gold futures lost 1.25% on Monday after reaching new monthly high of $1,775.80. It has retraced almost all of its month-long decline from April’s high. On April 14 it was the highest since November of 2012 and the high was at $1,788.80. The market has rev...
Paul Rejczak | May 19, 2020 |

Buzz on the Bullboards: Who Stands to Benefit the Most from Easing COVID Restrictions?

(Image via TAAT Lifestyle & Wellness Ltd.) Investors don’t prosper on potential. Investors prosper on returns. And in recent years, there haven’t been many mining companies able to reward return-starved investors with a strong stock p...
Stockhouse Editorial | February 22, 2022 |

Shaping the Future of Medicine by Delivering Regenerative Medicines

(Click image to play video) Envision a chest pain that feels like the most severe form of heartburn you ever experienced before. This is one of the main symptoms of ischemia – a disease which millions of people around the globe live with every day. Treati...
Dave Jackson | December 8, 2020 |

Reata Pharma Shares Trading Higher After Reacquiring U.S. and Worldwide Licensing Rights

Shares of Reata Pharmaceuticals are trading 12% higher today after the firm announced it had reacquired all licensing rights in the U.S. for bardoxolone methyl and worldwide rights for omaveloxolone and other next-generation Nrf2 activators from AbbVie. Clinical-stage...
Streetwise Reports | October 15, 2019 |

Buzz on the Bullboards: Six More Weeks of Volatility?

If you haven’t heard, the groundhog saw his shadow, and if the snowfall on the East and West coasts weren’t enough of an indication, it looks like winter may be with us for awhile still … along with COVID and its variants, which are still a...
Stockhouse Editorial | February 2, 2022 |
1 2 3 4 5 6 7 8 9 10 ...